[go: up one dir, main page]

AR059935A1 - Composicion farmaceutica para la prevencion o tratamiento del sindrome de colon irritable - Google Patents

Composicion farmaceutica para la prevencion o tratamiento del sindrome de colon irritable

Info

Publication number
AR059935A1
AR059935A1 ARP070101099A ARP070101099A AR059935A1 AR 059935 A1 AR059935 A1 AR 059935A1 AR P070101099 A ARP070101099 A AR P070101099A AR P070101099 A ARP070101099 A AR P070101099A AR 059935 A1 AR059935 A1 AR 059935A1
Authority
AR
Argentina
Prior art keywords
optionally substituted
prevention
pharmaceutical composition
treatment
group
Prior art date
Application number
ARP070101099A
Other languages
English (en)
Inventor
N Inatomi
J Terauchi
F Sato
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38522471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR059935(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of AR059935A1 publication Critical patent/AR059935A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

Reivindicacion 1: Una composicion farmacéutica para la prevencion o tratamiento del síndrome de colon irritable caracterizado porque comprende un compuesto representado por la formula (1):donde, R1 representa un grupo hidrocarbonado opcionalmente sustituido, un grupo amino opcionalmente sustituido o un grupo heterocíclico opcionalmente sustituido, R2 representa un átomo de hidrogeno o un grupo hidrocarbonado opcionalmente sustituido, R3 representa un átono de hidrogeno o un grupo hidrocarbonado opcionalmente sustituido o un grupo heterocíclico opcionalmente sustituido, X representa CHR4, NR4, CO, O o S (donde, R4 representa un átono de hidrogeno, un grupo hidrocarbonado opcionalmente sustituido o grupo hidroxilo), Y representa C, CH o N, ---- representa un simple o doble enlace, el anillo A representa un anillo heterocíclico de 5 a 7 miembros opcionalmente sustituido que contiene un átono de oxígeno, el anillo B representa un anillo de benceno opcionalmente sustituido y m representa un numero entero de 1 a 4, o una sal del mismo.
ARP070101099A 2006-03-20 2007-03-19 Composicion farmaceutica para la prevencion o tratamiento del sindrome de colon irritable AR059935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006076532 2006-03-20

Publications (1)

Publication Number Publication Date
AR059935A1 true AR059935A1 (es) 2008-05-07

Family

ID=38522471

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101099A AR059935A1 (es) 2006-03-20 2007-03-19 Composicion farmaceutica para la prevencion o tratamiento del sindrome de colon irritable

Country Status (19)

Country Link
US (2) US20090048325A1 (es)
EP (1) EP1997488A4 (es)
JP (1) JP5219799B2 (es)
KR (1) KR20080114743A (es)
CN (1) CN101404994A (es)
AR (1) AR059935A1 (es)
AU (1) AU2007228087A1 (es)
BR (1) BRPI0708805A2 (es)
CA (1) CA2644181A1 (es)
CR (1) CR10267A (es)
IL (1) IL193686A0 (es)
MA (1) MA30326B1 (es)
MX (1) MX2008011969A (es)
NO (1) NO20084214L (es)
PE (1) PE20080122A1 (es)
RU (1) RU2008141305A (es)
TW (1) TW200803837A (es)
WO (1) WO2007108442A1 (es)
ZA (1) ZA200807752B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023059546A1 (en) * 2021-10-04 2023-04-13 Psilosterics, Llc Serotonin receptor agonists and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326192D0 (en) * 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
SK283970B6 (sk) * 1996-03-08 2004-06-08 Takeda Chemical Industries, Ltd. Tricyklické zlúčeniny, spôsob výroby a farmaceutický prípravok ich obsahujúci
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
AU4060599A (en) * 1998-06-09 1999-12-30 Takeda Chemical Industries Ltd. Pharmaceutical composition for treating or preventing sleep disorders
FR2795323B1 (fr) * 1999-06-23 2001-11-16 Adir Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal
JP2002226367A (ja) 2001-02-02 2002-08-14 Fuji Chem Ind Co Ltd 薬物障害の予防または治療剤
US20050203130A1 (en) * 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
AR056076A1 (es) * 2005-09-20 2007-09-19 Takeda Pharmaceutical Agente profilactico o terapeutico para el desorden de sueno
US20070088079A1 (en) * 2005-09-20 2007-04-19 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for sleep disorder
US8138174B2 (en) * 2007-01-10 2012-03-20 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition

Also Published As

Publication number Publication date
PE20080122A1 (es) 2008-04-24
IL193686A0 (en) 2009-08-03
EP1997488A1 (en) 2008-12-03
TW200803837A (en) 2008-01-16
EP1997488A4 (en) 2010-04-21
AU2007228087A1 (en) 2007-09-27
MA30326B1 (fr) 2009-04-01
WO2007108442A1 (ja) 2007-09-27
CR10267A (es) 2008-11-18
MX2008011969A (es) 2008-10-03
US20100267821A1 (en) 2010-10-21
CA2644181A1 (en) 2007-09-27
JPWO2007108442A1 (ja) 2009-08-06
ZA200807752B (en) 2009-12-30
KR20080114743A (ko) 2008-12-31
CN101404994A (zh) 2009-04-08
RU2008141305A (ru) 2010-04-27
US20090048325A1 (en) 2009-02-19
US8183285B2 (en) 2012-05-22
NO20084214L (no) 2008-10-08
JP5219799B2 (ja) 2013-06-26
BRPI0708805A2 (pt) 2011-06-14

Similar Documents

Publication Publication Date Title
AR065806A1 (es) Derivados de quinolina, procesos para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de la artritis reumatoidea.
CU24030B1 (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
AR070479A1 (es) Derivado heterociclico fusionado y su uso
BRPI0906348A2 (pt) composto representado pela fórmula (1), composição farmacêutica; inibidor pai-1 e medicamento para prevenção para prevenção e/ou tratamento terapêutico de doença causada pela manifestação de pai-1 ou pelo aumento da ação de pai-1
ATE539073T1 (de) Heterocyclylalkylderivate als neue inhibitoren von histondeacetylase
MX2010004893A (es) Compuesto heterociclico y composicion farmaceutica del mismo.
ECSP099330A (es) Compuesto de indol
ATE432272T1 (de) Aminophenylderivate als neue inhibitoren von histondeacetylase
EA200900023A1 (ru) Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
DE602007011302D1 (de) Ligustilid zur behandlung von erkrankungen des zentralen nervensystems
ATE556074T1 (de) Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
UY31712A1 (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
SV2010003459A (es) Derivados de pirimidina 934
WO2008061754A8 (en) Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression
AR070263A1 (es) Derivados de oxazepinopirimidinona arilamido sustituidos, utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas y otras, medicamentos que los contienen y proceso de preparacion e intermediarios.
PT2280706E (pt) Composições compreendendo derivados de benzeno que activam lipase de lipoproteína
CO6321240A2 (es) Compuestos de anillo fusionados como activadores de glucocinasa
PA8768301A1 (es) Nuevos derivados tricíclicos, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
CO6150175A2 (es) Compuesto triciclico y uso farmaceutico del mismo
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
AR059935A1 (es) Composicion farmaceutica para la prevencion o tratamiento del sindrome de colon irritable
AR068372A1 (es) Derivados de n-fenilacetamida, inhibidores de la enzima soat1, y composiciones farmaceuticas y cosmeticas que los contienen
TW200740781A (en) Novel compounds

Legal Events

Date Code Title Description
FB Suspension of granting procedure